VBI Vaccines, Inc. - Ordinary Shares (VBIV): Price and Financial Metrics


VBI Vaccines, Inc. - Ordinary Shares (VBIV): $3.30

-0.16 (-4.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VBIV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

VBIV POWR Grades


  • Momentum is the dimension where VBIV ranks best; there it ranks ahead of 55.81% of US stocks.
  • VBIV's strongest trending metric is Growth; it's been moving down over the last 48 weeks.
  • VBIV's current lowest rank is in the Quality metric (where it is better than 2.26% of US stocks).

VBIV Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for VBIV is 0.01 -- better than just 7.07% of US stocks.
  • VBIV's price/sales ratio is 978.77; that's higher than the P/S ratio of 99.27% of US stocks.
  • As for revenue growth, note that VBIV's revenue has grown -50.28% over the past 12 months; that beats the revenue growth of merely 4.74% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to VBI Vaccines Inc are MRAM, NSTG, GTHX, SMTC, and DUO.
  • Visit VBIV's SEC page to see the company's official filings. To visit the company's web site, go to www.vbivaccines.com.

VBIV Valuation Summary

  • VBIV's price/sales ratio is 1021.2; this is 8897.36% higher than that of the median Healthcare stock.
  • Over the past 243 months, VBIV's price/sales ratio has gone down 1426.5.
  • Over the past 243 months, VBIV's price/sales ratio has gone down 1426.5.

Below are key valuation metrics over time for VBIV.

Stock Date P/S P/B P/E EV/EBIT
VBIV 2021-08-31 1021.2 5.5 -14.6 -13.8
VBIV 2021-08-30 1004.2 5.4 -14.3 -13.5
VBIV 2021-08-27 1012.7 5.5 -14.4 -13.6
VBIV 2021-08-26 959.0 5.2 -13.7 -12.8
VBIV 2021-08-25 913.7 4.9 -13.0 -12.1
VBIV 2021-08-24 891.0 4.8 -12.7 -11.8

VBIV Growth Metrics

  • Its 3 year net cashflow from operations growth rate is now at -175.29%.
  • Its 5 year net income to common stockholders growth rate is now at -229.14%.
  • Its year over year price growth rate is now at 91.3%.
VBIV's revenue has moved up $40,000 over the prior 43 months.

The table below shows VBIV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 0.905 -48.957 -63.482
2021-03-31 0.947 -46.046 -55.519
2020-12-31 1.061 -47.05 -46.23
2020-09-30 1.471 -39.085 -41.743
2020-06-30 1.82 -37.863 -44.908
2020-03-31 2.276 -42.34 -48.565

VBIV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VBIV has a Quality Grade of F, ranking ahead of 2.32% of graded US stocks.
  • VBIV's asset turnover comes in at 0.004 -- ranking 414th of 677 Pharmaceutical Products stocks.
  • NOVN, CKPT, and ARWR are the stocks whose asset turnover ratios are most correlated with VBIV.

The table below shows VBIV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.004 -9.583 -1.419
2021-03-31 0.005 -8.508 -1.124
2020-12-31 0.006 -7.641 -1.240
2020-09-30 0.010 -5.345 -1.736
2020-06-30 0.014 -4.054 -3.663
2020-03-31 0.019 -3.171 -175.420

VBIV Stock Price Chart Interactive Chart >

Price chart for VBIV

VBIV Price/Volume Stats

Current price $3.30 52-week high $4.83
Prev. close $3.46 52-week low $2.07
Day low $3.30 Volume 2,208,500
Day high $3.43 Avg. volume 4,313,153
50-day MA $3.16 Dividend yield N/A
200-day MA $3.26 Market Cap 844.83M

VBI Vaccines, Inc. - Ordinary Shares (VBIV) Company Bio


VBI Vaccines Inc. develops vaccine candidates and novel technology platforms in Israel and internationally. It develops products based on eVLP, a platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccines platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.


VBIV Latest News Stream


Event/Time News Detail
Loading, please wait...

VBIV Latest Social Stream


Loading social stream, please wait...

View Full VBIV Social Stream

Latest VBIV News From Around the Web

Below are the latest news stories about VBI Vaccines Inc that investors may wish to consider to help them evaluate VBIV as an investment opportunity.

7 Penny Stocks Waiting on the FDA for Rocket Fuel

News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks.

Thomas Niel on InvestorPlace | September 9, 2021

When Will VBI Vaccines Inc. (NASDAQ:VBIV) Turn A Profit?

VBI Vaccines Inc. ( NASDAQ:VBIV ) is possibly approaching a major achievement in its business, so we would like to...

Yahoo | August 10, 2021

VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides Corporate Update

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of diseas

Business Wire | August 2, 2021

VBI Vaccines, Inc. (VBIV) Reports Q2 Loss, Misses Revenue Estimates

VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of 12.50% and -73.99%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 2, 2021

Earnings Preview: VBI Vaccines, Inc. (VBIV) Q2 Earnings Expected to Decline

VBI Vaccines, Inc. (VBIV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 23, 2021

Read More 'VBIV' Stories Here

VBIV Price Returns

1-mo -7.82%
3-mo -11.29%
6-mo 6.11%
1-year 7.14%
3-year 36.36%
5-year -7.04%
YTD 20.00%
2020 99.28%
2019 -13.75%
2018 -62.53%
2017 37.74%
2016 27.05%

Continue Researching VBIV

Here are a few links from around the web to help you further your research on VBI Vaccines Inc's stock as an investment opportunity:

VBI Vaccines Inc (VBIV) Stock Price | Nasdaq
VBI Vaccines Inc (VBIV) Stock Quote, History and News - Yahoo Finance
VBI Vaccines Inc (VBIV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9327 seconds.